P1.01-056 Quality of Life and Clinical Outcomes of Nivolumab as 2+ Line Treatment in Advanced Refractory NSCLC Pts: Interim Analysis
Saved in:
Published in | Journal of thoracic oncology Vol. 12; no. 11; p. S1916 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.11.2017
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 1556-0864 1556-1380 |
---|---|
DOI: | 10.1016/j.jtho.2017.09.710 |